Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Star Combo PharmaASX:S66 19 EV-to-OCF is 1.55 as of Sep. 17, 2026, which is 154% above its 10-year median of 0.61. GuruFocus rates ASX:S66 with a GF Score™ of 19/100 and a GF Value™ of A$0.13 (Fairly Valued). The stock has 4 warning signs investors should review. Among 1,999 Consumer Packaged Goods companies, Star Combo Pharma ranks better than 71.39% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Star Combo Pharma's Enterprise Value is A$5.09 Mil.
Star Combo Pharma's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was A$3.28 Mil. Therefore, Star Combo Pharma's EV-to-OCF for today is 1.55.
The historical rank and industry rank for Star Combo Pharma's EV-to-OCF or its related term are showing as below:
ASX:S66'
s EV-to-OCF Range Over the Past 10 Years
Min: -69.13 Med: 0.61 Max: 110
Current: 1.55
During the past 10 years, the highest EV-to-OCF of Star Combo Pharma was 110.00. The lowest was -69.13. And the median was 0.61.
ASX:S66's EV-to-OCF is ranked better than 71.39% of 1999
companies
in the Consumer Packaged Goods industry
Industry Median: 8.03
vs ASX:S66: 1.55
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Star Combo Pharma's PE Ratio (TTM) for today is calculated as:
Star Combo Pharma's share price for today is A$0.14.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Star Combo Pharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was A$0.003.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Star Combo Pharma EV-to-OCF Related Terms
Star Combo Pharma EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Star Combo Pharma's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, Star Combo Pharma's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Star Combo Pharma EV-to-OCF vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Star Combo Pharma's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Star Combo Pharma's EV-to-OCF falls into.
Star Combo Pharma's current Enterprise Value is A$5.09 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Star Combo Pharma's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was A$3.28 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Star Combo Pharma (ASX:S66) has a EV-to-OCF of 1.55 as of Sep. 17, 2026. This is 154% above median its historical median of 0.61. According to the industry distribution chart, Star Combo Pharma ranks #572 out of 1999 companies in the Consumer Packaged Goods industry, placing it in the top 28.6%.
Is Star Combo Pharma's EV-to-OCF too high?
Star Combo Pharma's current EV-to-OCF of 1.55 is 154% above median its 10-year median of 0.61. The Consumer Packaged Goods industry median EV-to-OCF is 8.03. Star Combo Pharma's value of 1.55 is 80.7% below this industry median. Based on the distribution chart, Star Combo Pharma ranks #572 out of 1999 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Star Combo Pharma has a GF Score™ of 19/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Star Combo Pharma's EV-to-OCF compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Star Combo Pharma ranks #572 out of 1999 companies for EV-to-OCF. This puts Star Combo Pharma in the upper half of its industry. The industry median EV-to-OCF is 8.03. Star Combo Pharma's value of 1.55 is 80.7% below this benchmark. While the company's 10-year median is 0.61 vs. the industry median of 8.03, Star Combo Pharma has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Consumer Packaged Goods company?
The median EV-to-OCF among Consumer Packaged Goods companies is 8.03, based on 1,999 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Star Combo Pharma's current EV-to-OCF of 1.55 is 80.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Consumer Packaged Goods industry, the median EV-to-OCF is 8.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Star Combo Pharma's current EV-to-OCF is 1.55, which is 154% above median its own 10-year median of 0.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Star Combo Pharma stock overvalued right now?
Based on GuruFocus' analysis, Star Combo Pharma (ASX:S66) is currently considered Fairly Valued. The stock's GF Value™ is A$0.13, compared to a current price of A$0.14 — trading 7.7% above its estimated fair value. The current EV-to-OCF is 1.55, which is 154% above median its 10-year median of 0.61 and 80.7% below the Consumer Packaged Goods industry median of 8.03. Star Combo Pharma's overall GF Score™ is 19/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Star Combo Pharma (ASX:S66), the current EV-to-OCF is 1.55 as of Sep. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Star Combo Pharma (ASX:S66) Overvalued in 2026?
Based on GuruFocus' analysis, Star Combo Pharma stock appears to be overvalued.
The current stock price of A$0.14 is trading 7.7% above its estimated GF Value™ of A$0.13.
GuruFocus considers Star Combo Pharma to be Fairly Valued.
Key valuation signals for ASX:S66:
EV-to-OCF: 1.55 (154% above median its 10-year median of 0.61)
GF Value™: A$0.13 vs. price of A$0.14 (7.7% above fair value)
Industry Position: 80.7% below the Consumer Packaged Goods median (#572 of 1999)
No single metric tells the full story. See the ASX:S66 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Star Combo Pharma Ltd is engaged in the manufacturing and distribution of food products and nutritional supplements. The company offers products such as Costar, Living Healthy, Amax, and J&K. It operates in two segments. The Star Combo segment engages in the development, manufacturing, marketing, and sales of natural health supplements and skincare products. The Austoyou retail business segment consists of the Australia-China e-commerce platform that offers product lines directly to Chinese health product consumers, and Koala Mall's two retail stores in Sydney. Geographically, it operates in China and Australia.
19GF Score
Get the complete analysis for ASX:S66
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:S66 has been successfully added to your 
